These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39190265)

  • 21. m6A methyltransferase METTL3 contributes to sympathetic hyperactivity post-MI via promoting TRAF6-dependent mitochondrial ROS production.
    Yang P; Wang Y; Ge W; Jing Y; Hu H; Yin J; Xue M; Wang Y; Li X; Li X; Shi Y; Tan J; Li Y; Yan S
    Free Radic Biol Med; 2023 Nov; 209(Pt 2):342-354. PubMed ID: 37898386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 Affects Spinal Cord Neuronal Apoptosis by Regulating Bcl-2 m6A Modifications After Spinal Cord Injury.
    Guo S; Lin T; Chen G; Shangguan Z; Zhou L; Chen Z; Shi T; Chen D; Wang Z; Liu W
    Neurospine; 2023 Jun; 20(2):623-636. PubMed ID: 37401082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.
    Li Q; Yang L; Zhang F; Liu J; Jiang M; Chen Y; Ren C
    Reproduction; 2023 Feb; 165(2):197-208. PubMed ID: 36445237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S; Jiang F; Chen F; Deng Y; Pan X
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 mediates SOX5 m6A methylation in bronchial epithelial cells to attenuate Th2 cell differentiation in T2 asthma.
    Chen Z; Shang Y; Zhang X; Duan W; Li J; Zhu L; Ma L; Xiang X; Jia J; Ji X; Gong S
    Heliyon; 2024 Apr; 10(7):e28884. PubMed ID: 38601672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner.
    Huang C; Duan Z; Chen B; Xia H; Wang G
    Adv Clin Exp Med; 2024 Aug; ():. PubMed ID: 39136331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
    Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
    Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
    Mol Biotechnol; 2024 Dec; 66(12):3538-3548. PubMed ID: 37897586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    Ni P; Pan K; Zhao B
    PLoS One; 2023; 18(8):e0289068. PubMed ID: 37549144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STM2457 Inhibits METTL3-Mediated m6A Modification of miR-30c to Alleviate Spinal Cord Injury by Inducing the ATG5-Mediated Autophagy.
    Chen G; Shangguan Z; Ye X; Chen Z; Li J; Liu W
    Neurospine; 2024 Sep; 21(3):925-941. PubMed ID: 39363472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.
    Li C; Xie P; Lv K; Yang Q; Mou Y
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39021178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
    Wang Y; Chen Y; Xiao H; Liu Z; Liu X; Feng Z; Sheng X; Peng B; Ren X; Xu L; Teng F; Yi Z; Niu Y; Xiang D; Xia Y; Geng B
    Cell Death Discov; 2024 Mar; 10(1):155. PubMed ID: 38538596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
    Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
    J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
    Zhang B; Qian R; Li X
    Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.
    Liu B; Xing Z; Song F; Li D; Zhao B; Xu C; Xia W; Ji H
    FASEB J; 2023 Jul; 37(7):e22974. PubMed ID: 37249328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
    He T; Xia H; Chen B; Duan Z; Huang C
    Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.